Clicky

Repligen Corporation(RGEN) News

Date Title
Jul 22 Netflix downgraded, Intel initiated: Wall Street's top analyst calls
Jul 21 Here's Why Repligen (RGEN) is a Strong Growth Stock
Jul 18 Repligen, Bruker, Fortrea, Azenta, and Biogen Stocks Trade Down, What You Need To Know
Jul 18 3 Reasons RGEN is Risky and 1 Stock to Buy Instead
Jul 17 Repligen to Report Second Quarter 2025 Financial Results
Jul 7 Repligen And 2 Other Stocks That May Be Trading Below Estimated Value
Jun 24 5 Insightful Analyst Questions From Repligen’s Q1 Earnings Call
May 27 Repligen Announces Publication of the Company’s 2024 Corporate Sustainability Report
May 22 Repligen Corporation to Present at William Blair Growth Conference
May 2 QGEN or RGEN: Which Is the Better Value Stock Right Now?
May 2 Repligen Corp. (RGEN) Slid On Uncertainty Related To U.S. Federal Government Spending On Healthcare
May 1 Jim Cramer on Regeneron Pharmaceuticals, Inc. (REGN): ‘Arguably The Most Innovative Biopharma Company I’ve Seen In The Last Two Decades’
May 1 Jim Cramer on Repligen Corporation (RGEN): ‘I’m Not Quite Ready to Stick My Neck Out on This One’
Apr 30 RGEN Q1 Earnings Call: Repligen Delivers Above-Consensus Revenue, Raises Sales Outlook Amid Tariff Uncertainty
Apr 30 Repligen's Q1 Earnings Beat Estimates, Revenues Surge Y/Y
Apr 30 Repligen Corp (RGEN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
Apr 30 Q1 2025 Repligen Corp Earnings Call
Apr 29 Repligen (RGEN) Tops Q1 Earnings and Revenue Estimates
Apr 29 Repligen (NASDAQ:RGEN) Posts Better-Than-Expected Sales In Q1, Full-Year Outlook Slightly Exceeds Expectations
Apr 29 Repligen: Q1 Earnings Snapshot